本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexeo Therapeutics

2.77
-0.2700-8.88%
成交量:73.84万
成交额:211.13万
市值:2.27亿
市盈率:-2.42
高:3.03
开:3.03
低:2.77
收:3.04
52周最高:10.99
52周最低:2.77
股本:8,204.63万
流通股本:5,122.95万
量比:0.80
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
净资产收益率:-46.76%
总资产收益率:-27.59%
市净率:0.97
市盈率(LYR):-1.49

数据加载中...

2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

SEC问询函

Form CORRESP - Correspondence
2024/04/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report